King of Prussia, PA, United States of America

Nicholas E Levy

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nicholas E Levy

Introduction

Nicholas E Levy is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of antibodies. His work has implications for various applications in medical and pharmaceutical research.

Latest Patents

Nicholas E Levy holds a patent for "Methods for purifying antibodies." This invention relates to a method of purifying a recombinant polypeptide from Host Cell Proteins (HCP). The method involves applying a solution containing the recombinant polypeptide and HCP to a superantigen chromatography solid support. It also includes washing the solid support with a wash buffer comprising caprylate and arginine, followed by eluting the recombinant polypeptide from the solid support. This innovative approach enhances the efficiency of antibody purification processes.

Career Highlights

Nicholas E Levy is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and development efforts. His work in this prominent company underscores his commitment to innovation in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues, including Andre C Dumetz and Kent E Goklen. These partnerships reflect a collaborative spirit in the pursuit of scientific advancements.

Conclusion

Nicholas E Levy's contributions to antibody purification represent a significant advancement in biotechnology. His innovative methods and collaborations highlight the importance of teamwork in achieving breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…